Part 1 of this 6part CMECEcertified Medical Minute series discusses the current state of LAI AP underuse and reasons behind this gap in care Clinical evidence for LAI AP use in first episode or early in treatment to prevent relapse and hospitalization will provide evidencebased support for the use of LAI antipsychotics early in a patients treatment course
- Provider:Clinical Care Options
- Activity Link: https://clinicaloptions.com/CE-CME/neurology/lai-mm1-2024/25076-48026
- Start Date: 2024-08-21 05:00:00
- End Date: 2024-08-21 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Indivior Inc - Amount: 2272.72 - Is Kind Support: False Source: Otsuka America Pharmaceutical, Inc. - Amount: 4545.45 - Is Kind Support: False Source: Teva Pharmaceutical Industries - Amount: 22727.27 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest